8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed May 3, 2023 · 3y ago · Accession 0001171843-23-002790
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- May 3, 2023
- Report date
- May 3, 2023
- Document
- f8k_050323.htm
- Size
- 258 KB